
Around 195,000 people globally will be treated for this form of lung cancer in 2026

Genesis Research Group today announced the appointment of Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR. She joins the Executive Leadership Team and will lead the company’s global real-world evidence...

The company has invested $40bn in US R&D and manufacturing in the past seven years

The study found significant reductions of major cardiovascular events in high-risk adults following treatment

The investment is expected to generate up to 750 new jobs

The phase 3 study included around 2,600 patients

Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia,...

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

Almost one million new cases of gastric cancer are diagnosed globally every year

The Medscape Education Global team is excited to announce its participation in Swiss Biotech Day, taking place in Basel from May 5-6. This marks our inaugural attendance at this event,...

Immunoglobulin G4-related disease affects approximately 20,000 people in the US

Regulatory submissions are expected to be complete in the first half of this year